Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Epstein P < Epstein S < Eram M

S. L. Epstein
NONE (BIBLIO)
000217
000996
000C94
S.L. Epstein
NONE (BIBLIO)
000096
000202
000207
000306
000307
000434
000547
000548
000580
000A61
000A90
001618
SL Epstein
NONE (BIBLIO)
000038
000049
000058
000059
000061
000070
000173
000216
000266
000272
000321
000425
000435
000447
000456
000538
000582
000655
000667
000874
000A16
000A35
000A36
000B95
000C38
000C50
000C52
000C80
000C95
000E22
000E29
000E33
000E35
000E43
001030
001101
001141
001396
001696
SL. Epstein
NONE (BIBLIO)
000182
Slava Epstein
NONE (BIBLIO)
000461
Suzanne L. Epstein
États-Unis
Maryland
Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda
001536
États-Unis
Maryland
Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville
001538
États-Unis
Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD
Maryland
001850
001855
Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologies Evaluation and Research, Food and Drug AdministrationRockville, MarylandUSA2 aut.
États-Unis
Maryland
001589
001850
Gene Transfer and Immunogenicity Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration,Silver Spring, Maryland;
000272

<g>
<k>Epstein S</k>
<l>
<g>
<k>S. L. Epstein</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000217</i>
<i>000996</i>
<i>000C94</i>
</l>
<n>3</n>
<t>3</t>
</g>
</l>
<n>1</n>
<t>3</t>
</g>
<g>
<k>S.L. Epstein</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000096</i>
<i>000202</i>
<i>000207</i>
<i>000306</i>
<i>000307</i>
<i>000434</i>
<i>000547</i>
<i>000548</i>
<i>000580</i>
<i>000A61</i>
<i>000A90</i>
<i>001618</i>
</l>
<n>12</n>
<t>12</t>
</g>
</l>
<n>1</n>
<t>12</t>
</g>
<g>
<k>SL Epstein</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000038</i>
<i>000049</i>
<i>000058</i>
<i>000059</i>
<i>000061</i>
<i>000070</i>
<i>000173</i>
<i>000216</i>
<i>000266</i>
<i>000272</i>
<i>000321</i>
<i>000425</i>
<i>000435</i>
<i>000447</i>
<i>000456</i>
<i>000538</i>
<i>000582</i>
<i>000655</i>
<i>000667</i>
<i>000874</i>
<i>000A16</i>
<i>000A35</i>
<i>000A36</i>
<i>000B95</i>
<i>000C38</i>
<i>000C50</i>
<i>000C52</i>
<i>000C80</i>
<i>000C95</i>
<i>000E22</i>
<i>000E29</i>
<i>000E33</i>
<i>000E35</i>
<i>000E43</i>
<i>001030</i>
<i>001101</i>
<i>001141</i>
<i>001396</i>
<i>001696</i>
</l>
<n>39</n>
<t>39</t>
</g>
</l>
<n>1</n>
<t>39</t>
</g>
<g>
<k>SL. Epstein</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000182</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>Slava Epstein</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000461</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>Suzanne L. Epstein</k>
<l>
<g>
<k>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda</wicri:cityArea>
</affiliation>
</k>
<l>
<i>001536</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville</wicri:cityArea>
</affiliation>
</k>
<l>
<i>001538</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l>
<i>001850</i>
<i>001855</i>
</l>
<n>2</n>
<t>2</t>
</g>
<g>
<k>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologies Evaluation and Research, Food and Drug Administration</s1>
<s2>Rockville, Maryland</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l>
<i>001589</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation></affiliation>
</k>
<l>
<i>001850</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation>
<nlm:aff id="AF0001">
<institution>Gene Transfer and Immunogenicity Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration</institution>
,
<addr-line>Silver Spring, Maryland</addr-line>
;</nlm:aff>
</affiliation>
</k>
<l>
<i>000272</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>6</n>
<t>7</t>
</g>
</l>
<n>6</n>
<t>63</t>
</g>

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021